Jubilant Pharmova Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Jubilant Pharmova Limited's balance sheet done over the years? Its assets were worth $115,485,000,000 last year, which is more than in the previous period. 53% of Jubilant Pharmova Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $61,274,000,000, which means an increase by 31% compared compared to last year.
Debt to Assets
| 2011 | 75638540000 | 53.49B | 70.73% |
|---|---|---|---|
| 2012 | 78459190000 | 54.47B | 69.43% |
| 2015 | 86322150000 | 61.78B | 71.58% |
| 2016 | 89470240000 | 60.37B | 67.48% |
| 2018 | 96176180000 | 55.82B | 58.05% |
| 2019 | 114685050000 | 66.59B | 58.07% |
| 2020 | 125216520000 | 69.17B | 55.25% |
| 2021 | 89181100000 | 41.76B | 46.83% |
| 2022 | 99908670000 | 46.74B | 46.79% |
| 2024 | 115485000000 | 61.27B | 53.06% |
JUBLPHARMA.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 9.53B | 9.80B | 4.97B | 12.25B | 9.99B | 2.39B | 3.40B | 3.90B | 2.67B | 10.45B |
Short term investments | 87M | 53.53M | 1.87B | 1.87B | 3.77B | 294.56M | 53.16M | 66.48M | 0 | 0 |
Net receivables | 10.13B | 12.65B | 11.37B | 17.77B | 17.86B | 11.78B | 9.50B | 9.20B | 0 | 0 |
Inventory | 13.03B | 12.54B | 11.29B | 18.45B | 14.17B | 13.91B | 12.16B | 12.35B | 10.20B | 6.91B |
Other current assets | 6.02B | 32.94M | 3.22M | 25.9M | 41.91M | 3.16B | 3.57B | 1.61B | 10.56B | 10.85B |
Total current assets | 38.76B | 35.09B | 29.52B | 50.38B | 45.84B | 31.89B | 29.01B | 27.27B | 23.43B | 28.22B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 36.87B | 27.91B | 25.75B | 42.87B | 38.87B | 34.92B | 32.46B | 31.85B | 31.15B | 29.91B |
Goodwill | 24.63B | 22.42B | 21.29B | 20.89B | 19.58B | 18.87B | 18.31B | 17.32B | 0 | 15.83B |
Intangible assets | 10.43B | 9.26B | 8.00B | 7.31B | 7.03B | 6.91B | 6.07B | 5.89B | 20.29B | 938.3M |
Long term investments | 422M | 2.38B | 2.54B | 693.64M | -2.61B | 940.66M | 865.83M | 394.96M | 0 | 0 |
Other non-current assets | 2.03B | 1.21B | 510.71M | 943.39M | 4.46B | 1.01B | 1.89B | 3.96B | 3.46B | 327.52M |
Total non-current assets | 76.72B | 64.81B | 59.65B | 74.83B | 68.83B | 64.27B | 60.45B | 59.04B | 55.02B | 47.41B |
Total assets | 115.48B | 99.90B | 89.18B | 125.21B | 114.68B | 96.17B | 89.47B | 86.32B | 78.45B | 75.63B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 865M | 3.56B | 3.57B | -9.32B | 275.75M | 761.09M | 469.7M | 0 | 0 | 0 |
Short term debt | 2.99B | 5.15B | 701.35M | 9.32B | 5.97B | 4.21B | 14.80B | 11.01B | 7.67B | 0 |
Total current liabilities | 18.89B | 15.91B | 10.48B | 26.19B | 20.89B | 20.04B | 25.14B | 21.42B | 22.12B | 12.14B |
| Non-current liabilities: | ||||||||||
Long term debt | 33.64B | 26.76B | 27.59B | 38.75B | 42.42B | 30.47B | 30.15B | 36.91B | 28.39B | 39.24B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.10B |
Other non-current liabilities | 1.18B | 961.7M | 1.13B | 1.51B | 1.14B | 3.59B | 4.04B | 11.64M | 1.70B | 0 |
Total non-current liabilities | 42.38B | 30.82B | 31.27B | 42.98B | 45.69B | 35.77B | 35.22B | 40.36B | 32.34B | 41.35B |
Total liabilities | 61.27B | 46.74B | 41.76B | 69.17B | 66.59B | 55.82B | 60.37B | 61.78B | 54.47B | 53.49B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |